Profiling and in vivo quantification of proteins by high resolution mass spectrometry: The example of goserelin, an analogue of luteinizing hormone-releasing hormone

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 12, 2003, Pages 1589-1598

  Michalet, Sophie ^a   Favreau, Philippe ^a   Stöcklin, Reto ^a  

^a ATHERIS LABORATORIES   (Switzerland)

Author keywords

Buserelin; Diagnostics; Electrospray ionization mass spectrometry: ESI MS; Goserelin; Isotope dilution assay; Isotopes; Liquid chromatography mass spectrometry: LC MS; Luteinizing hormone releasing hormone: LHRH; Mass spectrometry; Pharmacodynamics; Pharmacokinetics; Post proteomics; Proteins; Quantification; Tandem mass spectrometry: MS MS

Indexed keywords

GONADORELIN DERIVATIVE; GOSERELIN;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEOMICS; QUADRUPOLE MASS SPECTROMETRY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL PROCESSING; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GOSERELIN; RATS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0346728538     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.242     Document Type: Article

References (46)

1. Jasuja R. Report RB-114R - protein drugs: manufacturing technologies. Business Communications Co., Inc., 2000.
2. Mallat A, Pavoine C, Dufour M, Lotersztajn S, Bataille D, Pecker F. A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. Nature 1987; 325:620-2.
3. Lotersztajn S, Pavoine C, Brechler V, Roche B, Dufour M, Le Nguyen D, et al. Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins. J Biol Chem 1990; 265:9876-80.
4. Lammertsma AA. Radioligand studies: imaging and quantitative analysis. Eur Neuropsychopharmacol 2002; 12:513-6.
5. Liu Z, Barrett EJ. Human protein metabolism: its measurement and regulation. Am J Physiol Endocrinol Metab 2002; 283:E1105-E1112.
6. Morishima T, Pye S, Bradshaw C, Radziuk J. Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state. Am J Physiol 1992; 263:E772-E779.
7. Pye S, Watarai T, Davies G, Radziuk J. Comparison of the continuously calculated fractional splanchnic extraction of insulin with its fractional disappearance using a new double-tracer technique. Metabolism 1993; 42:145-53.
8. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993; 39:2146-50.
9. Temple RC, Clark PM, Nagi DK, Schneider AE, Yudkin JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf) 1990; 32:689-93.
10. Tice JA, Browner W, Tracy RP, Cummings SR. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am J Med 2003; 114:199-205.
11. Clark PM, Levy JC, Cox L, Burnett M, Turner RC, Hales CN. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1992; 35:469-74.
12. Hage DS. Clinical applications of high-performance affinity chromatography. Adv Chromatogr 2003; 42:377-420.
13. Benzi L, Cecchetti P, Ciccarone A, Pilo A, Di Cianni G, Navalesi R. Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes 1994; 43:297-304.
14. Cockram CS, Jones RH, Boroujerdi MA, Sonksen P. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers. Diabetes 1984; 33:721-7.
15. Saric T, Seitz HJ, Pavelic K. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme. Mol Cell Endocrinol 1994; 106:23-9.
16. Wolthers BG, Kraan GP. Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. J Chromatogr A 1999; 843:247-74.
17. Dueker SR, Jones AD, Clifford AJ. Protocol development for biological tracer studies. Adv Exp Med Biol 1998; 445: 363-78.
18. Ong SE, Foster LJ, Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods 2003; 29:124-30.
19. Domon B, Alving K, He T, Ryan TE, Patterson SD. Enabling parallel protein analysis through mass spectrometry. Curr Opin Mol Ther 2002; 4:577-86.
20. Mano N, Goto J. Biomedical and biological mass spectrometry. Anal Sci 2003; 19:3-14.
21. Bakhtiar R, Nelson RW. Electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry. Emerging technologies in biomedical sciences. Biochem Pharmacol 2000; 59:891-905.
22. Cohen S, Chait BT. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem 1996; 68:1-31.
23. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis 1995; 16:1791-814.
24. Stöcklin R, Vu L, Vadas L, Cerini F, Kippen AD, Offord RE, et al. A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry. Diabetes 1997; 46:44-50.
25. Kobayashi N, Kanai M, Seta K, Nakamura K. Quantitative analysis of synthetic human calcitonin by liquid chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1995; 672:17-23.
26. Niwa M, Enomoto K, Yamashita K. Measurement of the novel decapeptide cetrorelix in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 1999; 729:245-53.
27. Marshall P, Heudi O, McKeown S, Amour A, Abou-Shakra F. Study of bradykinin metabolism in human and rat plasma by liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002; 16:220-8.
28. Guzman NA. Determination of immunoreactive gonadotropin-releasing hormone in serum and urine by on-line immunoaffinity capillary electrophoresis coupled to mass spectrometry. J Chromatogr B Biomed Sci Appl 2000; 749:197-213.
29. Bucknall M, Fung KY, Duncan MW. Practical quantitative biomedical applications of MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom 2002; 13:1015-27.
30. Kokko KP, Dix TA. Monitoring neurotensin[8-13] degradation in human and rat serum utilizing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 2002; 308:34-41.
31. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21:1164-77.
32. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 2002; 292:587-92.
33. Fierens C, Thienpont LM, Stöckl D, De Leenheer AP. Matrix effect in the quantitative analysis of urinary C-peptide by liquid chromatography/mass spectrometry [letter]. Rapid Commun Mass Spectrom 2000; 14:936-7.
34. Desiderio DM, Zhu X. Quantitative analysis of methionine enkephalin and beta-endorphin in the pituitary by liquid secondary ion mass spectrometry and tandem mass spectrometry. J Chromatogr A 1998; 794:85-96.
35. Vogeser M. Liquid chromatography-tandem mass spectrometry - application in the clinical laboratory. Clin Chem Lab Med 2003; 41:117-26.
36. De Leenheer AP, Lefevere MF, Lambert WE, Colinet ES. Isotope-dilution mass spectrometry in clinical chemistry. Adv Clin Chem 1985; 24:111-61.
37. Stöcklin R, Rose K, Green BN, Offord RE. The semisynthesis of [octadeutero-PheB1-octadeutero-ValB2]-porcine insulin and its characterization by mass spectrometry. Protein Eng 1994; 7:285-9.
38. Kippen AD, Cerini F, Vadas L, Stöcklin R, Vu L, Offord RE, et al. Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay. J Biol Chem 1997; 272:12513-22.
39. Stöcklin R, Arrighi JF, Hoang-Van K, Vu L, Cerini F, Gilles N, et al. Positive and negative labeling of human proinsulin, insulin, and C-peptide with stable isotopes. New tools for in vivo pharmacokinetic and metabolic studies [in process citation]. Methods Mol Biol 2000; 146:293-315.
40. Fierens C, Thienpont LM, Stöckl D, Willekens E, De Leenheer AP. Quantitative analysis of urinary C-peptide by liquid chromatography-tandem mass spectrometry with a stable isotopically labelled internal standard [in process citation]. J Chromatogr A 2000; 896:275-8.
41. Barr JR, Maggio VL, Patterson DG, Jr, Cooper GR, Henderson LO, Turner WE, et al. Isotope dilution - mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 1996; 42:1676-82.
42. Dewey RS, Liesch JM, Williams HR, Sugg EE, Dolan CA, Davies P, et al. Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated A alpha (1-21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187. Biochem J 1992; 281: 519-24.
43. Bonenfant D, Schmelzle T, Jacinto E, Crespo JL, Mini T, Hall MN, et al. Quantitation of changes in protein phosphorylation: a simple method based on stable isotope labeling and mass spectrometry. Proc Natl Acad Sci USA 2003; 100:880-5.
44. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17:994-9.
45. Beardsley RL, Reilly JP. Quantitation using enhanced signal tags: a technique for comparative proteomics. J Proteome Res 2003; 2:15-21.
46. Stöcklin R, Mebs D, Boulain JC, Panchaud PA, Virelizier H, Gillard-Factor C. Identification of snake species by toxin mass fingerprinting of their venoms. Methods Mol Biol 2000; 146:317-35.